4//SEC Filing
Singh Shawn 4
Accession 0001415889-24-018279
CIK 0001411685other
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 9:31 PM ET
Size
5.9 KB
Accession
0001415889-24-018279
Insider Transaction Report
Form 4
Singh Shawn
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2024-06-24+500,000→ 500,000 totalExercise: $3.23Exp: 2034-06-24→ Common Stock (500,000 underlying)
Footnotes (1)
- [F1]Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Equity Omnibus Incentive Plan, as amended. The Options will begin vesting on June 24, 2024 (the "Vesting Start Date"), and will vest in equal monthly installments over a three-year period until the Options become fully vested on the three (3) year anniversary of the Vesting Start Date.
Documents
Issuer
Vistagen Therapeutics, Inc.
CIK 0001411685
Entity typeother
Related Parties
1- filerCIK 0001412071
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 9:31 PM ET
- Size
- 5.9 KB